Dr. Todd Earl Abbott, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton-wellesley Hospital, Newton, MA 02462 Phone: 434-964-1637 |
Jonathan Neil Glickman, M.D., PHD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 320 Needham Street, Suite 200, Newton, MA 02464 Phone: 617-969-4100 Fax: 617-969-3393 |
Dr. Timothy Robert Quinn, M.D. Pathology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 2 Wells Ave, Newton, MA 02459 Phone: 617-658-9300 Fax: 617-658-9399 |
Dr. Nicole A Mihok, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 2014 Washington Street, Newton-wellesley Hospital, Newton, MA 02462 Phone: 617-243-6913 |
Carol J Chirolas, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 199 Concord St, Newton, MA 02462 Phone: 202-330-1357 |
Dr. Julie D Reimann, MD, PHD Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 2 Wells Ave, Newton, MA 02459 Phone: 855-644-3376 Fax: 617-658-9399 |
Yogeshwar Dayal, M.D. Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 190 Hartman Rd, Newton, MA 02459 Phone: 617-965-2569 |
Dr. Helen E Cajigas, MD, FCAP, MRO Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 831 Beacon St, Newton, MA 02459 Phone: 617-388-0476 |
Dr. Daniel David Koelliker, M.D. Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Pathology Department, Newton-wellesley Hospital, Newton, MA 02462 Phone: 617-243-6140 Fax: 617-243-5809 |
Lalita Gandbhir, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 215 Hartman Rd, Newton, MA 02459 Phone: 978-632-3420 |
Michael Jay Ross, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Department Of Pathology, Newton, MA 02462 Phone: 617-243-6140 Fax: 617-243-5809 |
Dr. Jeremy Stuart Ditelberg, M.D. Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 320 Needham Street, Suite 200, Newton, MA 02464 Phone: 617-969-4100 Fax: 617-969-3393 |
Kenan Joel Sauder, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-5276 |
Dr. Michael J Misialek, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6854 Fax: 617-243-5809 |
News Archive
Delcath Systems, Inc. today announced that the Company's Galway, Ireland location has achieved ISO 13485:2003 Certification—an internationally recognized quality standard designed to ensure that medical device manufacturers have the necessary comprehensive quality management systems in place to safely design, develop, manufacture and distribute medical devices in the European Union.
Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
A new, inexpensive urine test accurately identifies patients at risk for kidney damage after open heart surgery, allowing for corrective action before permanent injury occurs, according to research presented today at the 14th Annual Multidisciplinary Cardiovascular and Thoracic Critical Care Conference from The Society of Thoracic Surgeons.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
› Verified 4 days ago